BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15031366)

  • 1. Post-transplantation swelling of the lower eyelid.
    Koenig K; Briese S; Wiemann D; Haffner D; Querfeld U
    Nephrol Dial Transplant; 2004 Apr; 19(4):1001-3. PubMed ID: 15031366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Post-transplant lympho-proliferative disease associated to Epstein-Barr virus].
    Sánchez Fructuoso AI
    Nefrologia; 2005; 25(1):20-30. PubMed ID: 15789533
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
    Boratyńska M; Smolska D
    Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
    [No Abstract]   [Full Text] [Related]  

  • 4. A post-transplant complication.
    Singh M; McNamara C; Child F; Orteu CH
    Clin Exp Dermatol; 2009 Mar; 34(2):275-6. PubMed ID: 19187316
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Bar-Natan M; Nagler A
    Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a difference between Hodgkin's disease and a Hodgkin's-like post-transplant lymphoproliferative disorder, and why should that be of any interest?
    Ranganathan S; Jaffe R
    Pediatr Transplant; 2004 Feb; 8(1):6-8. PubMed ID: 15009835
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disorders of oral cavity.
    Ojha J; Islam N; Cohen DM; Marshal D; Reavis MR; Bhattacharyya I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):589-96. PubMed ID: 18442744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
    Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
    J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
    Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH
    Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Epstein Barr virus reactivation in islet after kidney transplantation.
    Cure P; Froud T; Leitão CB; Pileggi A; Tharavanij T; Bernetti K; Baidal DA; Selvaggi G; Ricordi C; Alejandro R
    Transplantation; 2008 Nov; 86(9):1324-5. PubMed ID: 19005419
    [No Abstract]   [Full Text] [Related]  

  • 11. Costimulation blockade with belatacept in renal transplantation.
    Dharnidharka VR
    N Engl J Med; 2005 Nov; 353(19):2085-6; author reply 2085-6. PubMed ID: 16282187
    [No Abstract]   [Full Text] [Related]  

  • 12. EBV-associated recurrent Hodgkin's disease after renal transplantation.
    Flanagan KH; Brennan DC
    Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated lymphoproliferative disorder presenting as apparently isolated gastrointestinal lesions in childhood.
    Sebire NJ; Malone M; Risdon RA; Ramsay AD
    Pediatr Dev Pathol; 2005; 8(1):88-91. PubMed ID: 15717118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
    Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
    Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant lymphoproliferative disorder presenting as epistaxis.
    Clarke JD; Stock D; Singh V
    J Laryngol Otol; 2004 Nov; 118(11):906-8. PubMed ID: 15638984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Virus, immunosuppression, and the kidney transplant recipient].
    Alberú J; Villasís A
    Rev Invest Clin; 2005; 57(4):582-95. PubMed ID: 16315643
    [No Abstract]   [Full Text] [Related]  

  • 19. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
    Leaver S; Amlot P; Thuraisingham R; Norton A; Aitken C; Cavenagh JD
    Clin Lab Haematol; 2004 Oct; 26(5):351-3. PubMed ID: 15485466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N; Torabineghad S; Rakei M
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.